|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Magenta Therapeutics (NASDAQ: MGTA) through any online brokerage.
The latest price target for Magenta Therapeutics (NASDAQ: MGTA) was reported by JP Morgan on August 3, 2021. The analyst firm set a price target for 7.00 expecting MGTA to rise to within 12 months (a possible 8.02% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Magenta Therapeutics (NASDAQ: MGTA) is $6.48 last updated Mon Oct 25 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Magenta Therapeutics.
Magenta Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Magenta Therapeutics.
Magenta Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.